PT67323A - Prolonged release pharmaceutical preparations - Google Patents
Prolonged release pharmaceutical preparationsInfo
- Publication number
- PT67323A PT67323A PT67323A PT6732377A PT67323A PT 67323 A PT67323 A PT 67323A PT 67323 A PT67323 A PT 67323A PT 6732377 A PT6732377 A PT 6732377A PT 67323 A PT67323 A PT 67323A
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical preparations
- release pharmaceutical
- prolonged release
- prolonged
- preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74532576A | 1976-11-26 | 1976-11-26 | |
US80010577A | 1977-05-24 | 1977-05-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT67323A true PT67323A (en) | 1977-12-01 |
PT67323B PT67323B (en) | 1979-04-24 |
Family
ID=27114439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT67323A PT67323B (en) | 1976-11-26 | 1977-11-25 | Prolonged release pharmaceutical preparations |
Country Status (21)
Country | Link |
---|---|
JP (1) | JPS609697B2 (en) |
AR (1) | AR218047A1 (en) |
AT (1) | AT359197B (en) |
AU (1) | AU511080B2 (en) |
BE (1) | BE861141A (en) |
CA (1) | CA1086226A (en) |
CH (1) | CH639560A5 (en) |
DE (1) | DE2752728C2 (en) |
DK (1) | DK150534C (en) |
FI (1) | FI65910C (en) |
FR (1) | FR2373288A1 (en) |
GB (1) | GB1544761A (en) |
GR (1) | GR61724B (en) |
IE (1) | IE45998B1 (en) |
IL (1) | IL53462A (en) |
LU (1) | LU78584A1 (en) |
NL (1) | NL182283C (en) |
NO (1) | NO147626C (en) |
NZ (1) | NZ185772A (en) |
PT (1) | PT67323B (en) |
SE (1) | SE426781B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2929456A1 (en) | 1979-07-20 | 1981-02-05 | Lentia Gmbh | COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT |
CA1236023A (en) * | 1984-07-18 | 1988-05-03 | Yegnaswami Raghunathan | Controlled release pharmaceutical preparations |
US4692462A (en) * | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
US5188825A (en) * | 1989-12-28 | 1993-02-23 | Iles Martin C | Freeze-dried dosage forms and methods for preparing the same |
DE69107461T2 (en) * | 1990-08-07 | 1995-06-22 | Pfizer | USE OF INTERFACIAL POLYMERIZED MEMBRANES IN DELIVERY DEVICES. |
US5436011A (en) * | 1993-04-16 | 1995-07-25 | Bristol-Myers Squibb Company | Solid pharmaceutical dosage form and a method for reducing abrasion |
US20130230587A1 (en) * | 2010-11-10 | 2013-09-05 | Rubicon Research Private Limited | Sustained release compositions |
FR3059903B1 (en) * | 2016-12-08 | 2019-03-22 | Salsarulo Pharma | ORAL MEDICINE COMPRISING AN OSMOTIC LAXATIVE INCORPORATED IN A MATRIX BASED ON VEGETABLE FATS |
KR20200097685A (en) | 2017-10-09 | 2020-08-19 | 로도스 파머시티컬스 엘.피. | Pharmaceutical resin acid salt composition and its preparation and use method |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE550150A (en) * | 1955-08-08 | |||
GB843118A (en) * | 1957-02-13 | 1960-08-04 | Ici Ltd | Pharmaceutical compositions containing piperidine derivatives |
US3158538A (en) * | 1961-02-23 | 1964-11-24 | White Lab Inc | Antidiarrheal compositions and method of using |
GB982150A (en) * | 1961-09-29 | 1965-02-03 | Glaxo Group Ltd | Therapeutic resin complexes |
US3594470A (en) * | 1968-02-19 | 1971-07-20 | Abbott Lab | Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin |
GB1218102A (en) * | 1968-03-15 | 1971-01-06 | Philips Nv | Improvements in medicaments comprising drug/ion-exchange resin compounds |
CA927282A (en) * | 1968-09-03 | 1973-05-29 | S. Banker Gilbert | Entrapment compositions and processes |
CA935092A (en) * | 1968-09-03 | 1973-10-09 | S. Banker Gilbert | Molecular drug entrapment process and compositions |
DE2343218C2 (en) * | 1973-08-28 | 1986-08-07 | Hoechst Ag, 6230 Frankfurt | Pellets containing furosemide |
-
1977
- 1977-11-24 FI FI773568A patent/FI65910C/en not_active IP Right Cessation
- 1977-11-24 CA CA291,664A patent/CA1086226A/en not_active Expired
- 1977-11-24 NZ NZ185772A patent/NZ185772A/en unknown
- 1977-11-24 GB GB48997/77A patent/GB1544761A/en not_active Expired
- 1977-11-24 BE BE182882A patent/BE861141A/en not_active IP Right Cessation
- 1977-11-24 GR GR54861A patent/GR61724B/en unknown
- 1977-11-24 IL IL53462A patent/IL53462A/en unknown
- 1977-11-24 JP JP52140093A patent/JPS609697B2/en not_active Expired
- 1977-11-25 DE DE2752728A patent/DE2752728C2/en not_active Expired
- 1977-11-25 NL NLAANVRAGE7712996,A patent/NL182283C/en not_active IP Right Cessation
- 1977-11-25 FR FR7735611A patent/FR2373288A1/en active Granted
- 1977-11-25 IE IE2391/77A patent/IE45998B1/en not_active IP Right Cessation
- 1977-11-25 LU LU78584A patent/LU78584A1/xx unknown
- 1977-11-25 SE SE7713370A patent/SE426781B/en not_active IP Right Cessation
- 1977-11-25 AU AU30986/77A patent/AU511080B2/en not_active Expired
- 1977-11-25 AR AR270132A patent/AR218047A1/en active
- 1977-11-25 CH CH1450177A patent/CH639560A5/en not_active IP Right Cessation
- 1977-11-25 NO NO774051A patent/NO147626C/en unknown
- 1977-11-25 AT AT848077A patent/AT359197B/en not_active IP Right Cessation
- 1977-11-25 PT PT67323A patent/PT67323B/en unknown
- 1977-11-25 DK DK523277A patent/DK150534C/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA783480B (en) | New pharmaceutical preparations | |
ZA803567B (en) | Pharmaceutical preparations | |
JPS52143218A (en) | Pharmaceutical composition | |
JPS52113976A (en) | Pharmaceutical composition | |
JPS5362838A (en) | Pharmaceutical composition | |
NZ180321A (en) | Sustained release pharmaceutical preparation | |
JPS5372814A (en) | Pharmaceutical composition | |
AU515157B2 (en) | Sustained release medicament | |
AU3152677A (en) | Pharmaceutical composition | |
IL53462A0 (en) | Prolonged release pharmaceutical preparations | |
JPS52128357A (en) | Antiitumor drug | |
AU2649977A (en) | Pharmaceutical composition | |
JPS5356634A (en) | Pharmaceutical composition | |
JPS51130425A (en) | Colddwaterrsoluble preparations | |
GB1541710A (en) | Anthelintic preparations | |
JPS5325579A (en) | Pharmaceutical compound | |
JPS5283918A (en) | Pharmaceutical composition | |
MY8400062A (en) | Pharmaceutical preparations for venotonic use | |
ZA776645B (en) | Pharmaceutical preparations | |
AU3149277A (en) | D-homosteroids and pharmaceutical preparation | |
JPS5338620A (en) | Isomalin antiimold drug | |
JPS52122633A (en) | Pharmaceutical composition | |
BG23573A1 (en) | Medicinal preparation | |
BG23572A1 (en) | Medicinal preparation | |
AU3210477A (en) | Pharmaceutical composition |